Canada markets closed

Molecular Pharmacology (USA), Ltd. (MLPH)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.00060.0000 (0.00%)
At close: 09:31AM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 223.11k
Enterprise Value 221.59k
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -2.11

Trading Information

Stock Price History

Beta (5Y Monthly) 55.12
52-Week Change 3500.00%
S&P500 52-Week Change 323.57%
52 Week High 30.0050
52 Week Low 30.0001
50-Day Moving Average 30.0007
200-Day Moving Average 30.0006

Share Statistics

Avg Vol (3 month) 33.1k
Avg Vol (10 day) 3210
Shares Outstanding 5111.55M
Implied Shares Outstanding 6356.97M
Float 8N/A
% Held by Insiders 1N/A
% Held by Institutions 1N/A
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2014
Most Recent Quarter (mrq)Sept 30, 2014

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-569.41%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -98.11k
Net Income Avi to Common (ttm)-105.18k
Diluted EPS (ttm)-0.0000
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.52k
Total Cash Per Share (mrq)0
Total Debt (mrq)2.08M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.28
Book Value Per Share (mrq)-0.02

Cash Flow Statement

Operating Cash Flow (ttm)-109.35k
Levered Free Cash Flow (ttm)-65.61k